TITLE

Onychmycosis: Long-term follow-up

PUB. DATE
April 2010
SOURCE
Internal Medicine Alert;4/29/2010, Vol. 32 Issue 8, p64
SOURCE TYPE
Periodical
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents," by B.M. Piraccini and colleagues is presented.
ACCESSION #
50747091

 

Related Articles

  • New oral antifungals share many commonalities. Campbell, Maude // Dermatology Times;Apr98 Supplement 2, Vol. 19 Issue 4, pS18 

    Discusses the similarities of three oral antifungal agents. Details on the commonalities of fluconazole, itraconazole and terbinafine; Adverse effects of the three agents; Safety of the three antifungal agents.

  • Are you using antiyeast creams correctly? Young, Stephanie // Glamour;Dec93, Vol. 91 Issue 12, p38 

    Presents tips on using antiyeast creams correctly. Use of preparations while menstruating; Non-use of tampoons during menstruation; Effect of antiyeast creams in diaphragms and condoms.

  • FDA approves another antifungal nail drug. Pfeiffer, Naomi // Drug Topics;6/24/96, Vol. 140 Issue 12, p38 

    Reports on the Food and Drug Administration's approval of the drug Lamisil or terbinafine hydrochloride indicated for toenail fungal infections. Manufacturer; Components; Dosage forms.

  • Antifungals in office dermatology. Lesher, Jack; Levine, Norman // Patient Care;3/15/1994, Vol. 28 Issue 5, p59 

    Part II. Presents guidelines for choosing antifungal medications. Active ingredient, formulations and indications of over-the-counter antifungal preparations; Oral medications for fungal infections; Duration of medication.

  • DaniPro Antifungal Nail Polish.  // Podiatry Management;Jan2012, Vol. 31 Issue 1, p201 

    No abstract available.

  • Antifungal solution for tinea.  // Modern Medicine;Dec97, Vol. 65 Issue 12, p45 

    Announces the availability of the solution form of the antifungal agent terbinafine hydrochloride. Indications; Advantage over the approved cream form.

  • Terbinafine (ter-BIN-a-feen) (oral).  // Drug Topics;7/8/96, Vol. 140 Issue 13, p71 

    Features the antifungal agent Terbinafine. Brand name; Dosage and storage of the medicine; Drugs and foods to avoid; Side effects.

  • Correction.  // American Journal of Health-System Pharmacy;5/1/2010, Vol. 67 Issue 9, p698 

    A correction to the article "Posaconazole: A new oral antifungal agent with an expanded spectrum of activity" in the February 1, 2009 issue is presented.

  • Topical antifungal agents: An update. Diehl, Kristine Burns // American Family Physician;10/1/1996, Vol. 54 Issue 5, p1687 

    Provides an update on topical antifungal agents. Difficulty associated with the selection of the proper agent for a given infection; Type of therapy which should be considered for fungal infection which relates to the scalp, nails or large areas of the skin; Effects of antifungal drugs on the...

  • Editorial. Nelson, Mark L. // Anti-Infective Agents in Medicinal Chemistry;2009, Vol. 8 Issue 1, p1 

    The article discusses various reports published within the issue, including one on polyfunctional antibiotics affecting bacterial cell membranes and another on a study of plant-derived antifungal agents.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics